trending Market Intelligence /marketintelligence/en/news-insights/trending/GKEGhaWKwlLdyIFEM9Oegg2 content esgSubNav
In This List

Atossa Genetics changes name to Atossa Therapeutics

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Atossa Genetics changes name to Atossa Therapeutics

Atossa Genetics Inc., a Seattle-based biopharmaceutical company, changed its name to Atossa Therapeutics Inc.

The company said the name change more clearly reflects its focus on developing therapies for breast cancer, breast density and other breast conditions.

Atossa's common stock will continue to trade on the NasdaqCM exchange under the ATOS symbol.